Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Connor

Showing results (761-770 of 778) with videos related to

Pageof 78
Sort By:
BMJ Open|July 20, 2024
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trialRobert D Little, Jo McKenzie, Ashish Srinivasan, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2016
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort studyJ D Doecke, F Hartnell, P Bampton, et al.
Contemporary Clinical Trials|April 16, 2026
The Imperial Prostate 9 - Approaches To Long-term Active Surveillance: Regular MRI scans versus standard of care (IP9-ATLAS) randomised controlled trialArchana Gopalakrishnan, Alexander Light, Nikhil Mayor, et al.
Inflammatory Bowel Diseases|December 3, 2025
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic EraHugh L Giddings, Kheng-Seong Ng, Michael J Solomon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2021
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal FistulasMichael De Gregorio, Tanya Lee, Krupa Krishnaprasad, et al.
Intestinal Research|November 4, 2024
Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease CoalitionFiliz Akyüz, Yoon Kyo An, Jakob Begun, et al.
Cancer Immunology Research|May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaRana R McKay, Dominick Bossé, Wanling Xie, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 12, 2025
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD ConsortiumYoon-Kyo An, Niamh Lindsay, Natalie Allan, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2015
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United StatesColleen S Kraft, Angela L Hewlett, Scott Koepsell, et al.
Pageof 78

Showing results (761-770 of 778) with videos related to

Sort By:
Pageof 78
BMJ Open|July 20, 2024
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trialRobert D Little, Jo McKenzie, Ashish Srinivasan, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2016
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort studyJ D Doecke, F Hartnell, P Bampton, et al.
Contemporary Clinical Trials|April 16, 2026
The Imperial Prostate 9 - Approaches To Long-term Active Surveillance: Regular MRI scans versus standard of care (IP9-ATLAS) randomised controlled trialArchana Gopalakrishnan, Alexander Light, Nikhil Mayor, et al.
Inflammatory Bowel Diseases|December 3, 2025
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic EraHugh L Giddings, Kheng-Seong Ng, Michael J Solomon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2021
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal FistulasMichael De Gregorio, Tanya Lee, Krupa Krishnaprasad, et al.
Intestinal Research|November 4, 2024
Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease CoalitionFiliz Akyüz, Yoon Kyo An, Jakob Begun, et al.
Cancer Immunology Research|May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaRana R McKay, Dominick Bossé, Wanling Xie, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 12, 2025
Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD ConsortiumYoon-Kyo An, Niamh Lindsay, Natalie Allan, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2015
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United StatesColleen S Kraft, Angela L Hewlett, Scott Koepsell, et al.
Pageof 78